Appointment of Josep M. Montserrat, Group leader
Sleep-related breathing disorders are underdiagnosed; their consequences are not clear and neither are the methods for diagnosing them

Current research


Sleep-related breathing disorders lack a cost-effective diagnostic method that is accessible to most patients. This makes it difficult to define a treatment that is both preventive and effective.


The group concentrates on three lines of work to optimise the management of sleep-related breathing disorders: basic experiments that enable us to understand these disorders; clinical experiments in patients to ascertain effects on them, and multicentre experiments designed to transfer knowledge gained from research to the healthcare system.


The group’s research in mice has made it possible to demonstrate that sleep apnoea is dangerous.

In addition, it has shown that telemedicine is a valid and cost-effective system for treating sleep-related breathing disorders, and that it is useful to treat them with CPAP, an appliance providing continuous positive airway pressure throughout the respiratory cycle.